BANK OF AMERICA CORP /DE/
BankPosition in AVXL — Anavex Life Sciences Corp.
CIK 70858
CHARLOTTE, NC
Position in AVXL
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$2,649,870
+$783,760 QoQ
Shares Held
863,150
+64.7% QoQ
Ownership
0.931%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Derivatives in AVXL
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$2,304,078
PutShares
249,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. AVXL ranks #165 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in AVXL
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,649,870 | 863,150 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,866,110 | 524,189 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,520,884 | 170,886 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,822,877 | 414,629 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $2,304,078 | 249,900 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $479,622 | 55,900 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $2,279,911 | 265,724 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,134,895 | 198,780 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,563,504 | 275,265 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $742,298 | 175,900 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $2,533,513 | 600,359 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,332,241 | 851,128 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $2,874,323 | 564,700 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $1,907,972 | 204,938 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,287,637 | 196,586 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,102,131 | 258,565 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $867,284 | 101,200 | Put | Defined | 2023-05-12 | |
| 2023-03-31 | $7,171,160 | 836,775 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,689,762 | 506,454 | Shares | Defined | 2023-02-10 | |
| 2022-12-31 | $937,112 | 101,200 | Put | Defined | 2023-02-10 | |
| 2022-09-30 | $2,597,666 | 251,712 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,130,448 | 112,932 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,363,374 | 273,223 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,571,000 | 148,270 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $17,950 | 1,000 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $566,626 | 31,567 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,439,102 | 150,442 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $2,666,838 | 178,384 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $95,552 | 17,695 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $94,219 | 20,708 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $115,086 | 23,392 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,651 | 2,429 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||